3/4
09:01 am
blte
Belite Bio price target raised to $266 from $200 at Cantor Fitzgerald [Yahoo! Finance]
Medium
Report
Belite Bio price target raised to $266 from $200 at Cantor Fitzgerald [Yahoo! Finance]
3/3
02:11 pm
blte
Belite Bio (BLTE) was given a new $217.00 price target by Needham & Company LLC.
Medium
Report
Belite Bio (BLTE) was given a new $217.00 price target by Needham & Company LLC.
3/3
01:35 pm
blte
Belite Bio (BLTE) had its price target raised by HC Wainwright from $185.00 to $200.00. They now have a "buy" rating on the stock.
Medium
Report
Belite Bio (BLTE) had its price target raised by HC Wainwright from $185.00 to $200.00. They now have a "buy" rating on the stock.
3/3
12:57 pm
blte
Belite Bio (BLTE) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
Medium
Report
Belite Bio (BLTE) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
3/3
12:11 pm
blte
Belite Bio (BLTE) had its "buy" rating reaffirmed by Benchmark Co..
Medium
Report
Belite Bio (BLTE) had its "buy" rating reaffirmed by Benchmark Co..
3/3
11:46 am
blte
Belite Bio (BLTE) had its price target raised by Morgan Stanley from $191.00 to $201.00. They now have an "overweight" rating on the stock.
Medium
Report
Belite Bio (BLTE) had its price target raised by Morgan Stanley from $191.00 to $201.00. They now have an "overweight" rating on the stock.
3/3
09:51 am
blte
Belite Bio (BLTE) had its price target raised by Cantor Fitzgerald from $200.00 to $266.00. They now have an "overweight" rating on the stock.
Low
Report
Belite Bio (BLTE) had its price target raised by Cantor Fitzgerald from $200.00 to $266.00. They now have an "overweight" rating on the stock.
3/2
06:35 pm
blte
Belite Bio Q4 Earnings Call Highlights [Yahoo! Finance]
Medium
Report
Belite Bio Q4 Earnings Call Highlights [Yahoo! Finance]
3/2
04:34 pm
blte
Belite Bio Non-GAAP EPS of -$0.19 beats by $0.38 [Seeking Alpha]
Medium
Report
Belite Bio Non-GAAP EPS of -$0.19 beats by $0.38 [Seeking Alpha]
3/2
08:11 am
blte
Belite Bio to Participate in the Leerink Global Healthcare Conference [Yahoo! Finance]
Medium
Report
Belite Bio to Participate in the Leerink Global Healthcare Conference [Yahoo! Finance]
3/2
08:00 am
blte
Belite Bio to Participate in the Leerink Global Healthcare Conference
Medium
Report
Belite Bio to Participate in the Leerink Global Healthcare Conference
3/2
06:18 am
blte
Belite Bio Reports Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update [Yahoo! Finance]
Medium
Report
Belite Bio Reports Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update [Yahoo! Finance]
3/2
06:00 am
blte
Belite Bio Reports Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update
Medium
Report
Belite Bio Reports Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update
2/23
08:13 am
blte
Belite Bio to Host Webcast on March 2, 2026, to Discuss Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
Medium
Report
Belite Bio to Host Webcast on March 2, 2026, to Discuss Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
2/23
08:00 am
blte
Belite Bio to Host Webcast on March 2, 2026, to Discuss Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Results
Medium
Report
Belite Bio to Host Webcast on March 2, 2026, to Discuss Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Results
2/19
09:16 am
blte
Belite Bio (NASDAQ:BLTE) was given a new $223.00 price target on by analysts at Mizuho.
Medium
Report
Belite Bio (NASDAQ:BLTE) was given a new $223.00 price target on by analysts at Mizuho.
1/29
08:00 am
blte
Belite Bio Announces Participation at the 41st Asia-Pacific Academy of Ophthalmology Congress (APAO)
Low
Report
Belite Bio Announces Participation at the 41st Asia-Pacific Academy of Ophthalmology Congress (APAO)
1/28
08:04 am
blte
Belite Bio (NASDAQ:BLTE) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $185.00 price target on the stock.
Low
Report
Belite Bio (NASDAQ:BLTE) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $185.00 price target on the stock.
1/27
12:51 pm
blte
Belite Bio On A Tear As It Approaches Key Regulatory Submissions [Seeking Alpha]
Low
Report
Belite Bio On A Tear As It Approaches Key Regulatory Submissions [Seeking Alpha]
1/27
08:00 am
blte
Belite Bio Completes Enrollment in the DRAGON II Clinical Trial of Tinlarebant for Stargardt Disease (STGD1)
Low
Report
Belite Bio Completes Enrollment in the DRAGON II Clinical Trial of Tinlarebant for Stargardt Disease (STGD1)
1/26
08:04 am
blte
Belite Bio (NASDAQ:BLTE) is now covered by analysts at Bank of America Corporation. They set a "buy" rating and a $195.00 price target on the stock.
Low
Report
Belite Bio (NASDAQ:BLTE) is now covered by analysts at Bank of America Corporation. They set a "buy" rating and a $195.00 price target on the stock.
1/6
07:07 am
blte
Belite Bio (NASDAQ:BLTE) was given a new $191.00 price target on by analysts at Morgan Stanley. They now have an "overweight" rating on the stock.
Low
Report
Belite Bio (NASDAQ:BLTE) was given a new $191.00 price target on by analysts at Morgan Stanley. They now have an "overweight" rating on the stock.
1/4
01:06 am
blte
12/27
01:05 am
blte
Medium
Report